Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

GARDP establishes India R&D Advisory Group to boost capacity and support future development

8 September 2020

The Global Antibiotic Research and Development Partnership (GARDP) has established an India Advisory Group for research and development to maximize Indian knowledge and capacity in support of GARDP’s work to develop new treatments for drug-resistant infections, for every person who needs them. This will include the development of networks and defining strategic priorities for research and development, as well as access, in India and internationally.

The objective of the advisory group is to support the development of new treatments by:

  • Leveraging and strengthening research and development capacity within country (including the Lifesciences and pharmaceutical industry)
  • Building partnerships and networks for mutual benefit
  • Leveraging funding to optimize investments in infectious disease research and development and access
  • Using the knowledge, expertise, and international networks of GARDP to benefit research and development programmes and partnerships within India
  • Interfacing with Regulators to sensitize them on best practices including global data harmonization
  • Interfacing with Government of India to help create sustainable market mechanisms to support AMR Innovation

The India Advisory Group includes:

  • Dr Anand Anandkumar, co-founder and CEO, Bugworks Research India Pvt. Ltd
  • Prof Y K Gupta, Principal Adviser (Project), THSTI – DBT ,GOI
  • Dr Harish Iyer, Senior Advisor, R&D and Life Sciences Partnerships, BMGF
  • Dr Shrishendu Mukherjee, Mission Director, BIRAC
  • Dr Camilla Rodrigues, Consultant Microbiology & Chairperson Infection Control Committee, Hinduja Hospital
  • Dr Zakir Thomas, in his individual capacity.
  • Dr Kamini Walia, Scientist F – Division of Epidemiology and Communicable Diseases, ICMR
  • Dr Suman Rijal, DNDi India Director will be the Secretary of this group.